Global Poliomyelitis Vaccine Market – Industry Trends and Forecast to 2029

소아마비 백신 시장 분석 및 규모

글로벌 소아마비 백신 시장은 예측 기간 동안 상당한 성장을 보일 것으로 예상됩니다. 소아마비 백신에 대한 인식 증가, 현재 소아마비 감염을 치료하기 위해 진행 중인 지속적인 임상 연구, WHO, 유니세프 및 기타 정부 기관에서 소아마비 감염을 치료하기 위한 백신을 조달함에 따라 소아마비 시장이 성장할 것입니다. 이에 더하여 치료 옵션의 발전과 잘 정립된 의료 시설의 존재는 소아마비 시장 수요에 영향을 미치는 주요 요인 중 일부입니다. COVID-19도 시장 성장에 큰 영향을 미쳤습니다.

Data Bridge Market Research는 2022-2029년 예측 기간 동안 글로벌 소아마비 백신 시장의 성장률을 분석합니다. 글로벌 소아마비 백신 시장의 예상 CAGR은 언급된 예측 기간 동안 약 6%인 경향이 있습니다. Data Bridge Market Research 팀이 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 시장 세그먼트, 지리적 범위, 시장 참여자 및 시장 시나리오와 같은 시장 통찰력 외에도 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크가 포함되어 있습니다.

시장 정의

소아마비는 매우 전염성이 강한 바이러스성 질환으로, 소아마비 바이러스가 인간의 신경계를 침범하여 몇 시간 만에 생명을 위협하는 심각한 장애와 돌이킬 수 없는 마비를 유발합니다. 이 바이러스는 사람과 사람의 접촉을 통해 퍼집니다. 소아마비에 대한 어린이 면역을 위해 개발된 경구 소아마비 백신(OPV)과 불활성화 소아마비 백신(IPV)과 같은 많은 소아마비 백신이 있습니다. OPV에는 이러한 바이러스의 생약독화 균주가 포함되어 있고 IPV에는 Mahoney 1형, MEF-1(Middle East Forces) 2형, Saukett 3형의 세 가지 소아마비 바이러스 균주가 포함되어 있습니다. OPV의 투여 경로는 경구이고 IPV의 투여 경로는 주사입니다.

소아마비 백신 시장 범위 및 세분화

Global Poliomyelitis Vaccine Market Dynamics

Drivers

• Rising Awareness

In the last few years, government and non-government organizations in developing countries, have made extreme efforts to raise awareness for preventive medicine. Several programs have been conducted that reach out to uneducated people, especially in rural areas. For instance, Polio eradication strategy 2022-2026 was launched by GPEI in the year 2020 has maintained a special goal for eradicating the remaining type of WPV1 and, validating the absence of cVDPV2 and also preparing for post-polio challenges. This is a key factor that boosts the Bacterial Vaccines Market in emerging economies of the world.

• Increased Mergers and Acquisitions

The poliomycetes vaccine market is expected to expand due to the rise in the number of mergers and acquisitions of major market players in the market. For instance, in April 2017, Serum Institute of India Pvt. Ltd. acquired U.S. USD 82.08 million for Nanotherapeutics, a Czech company. Serum Institute was able to upsurge its injectable polio vaccine manufacturing capacity to 200 million doses as a result of this acquisition.

Opportunities

• Growing Demand of Poliomyelitis Vaccination

The world population had a count of 7.9 billion in 2021, which needs to be prevented from polio virus and many other viruses. As per many studies, 179.8 thousand of the child birth was recorded in the year 2021. The world has achieved 99% reduction from the polio virus transmission and elimination of 5 out of 6 regions which comes under WHO. This boosts the market growth.

• Increasing Demand for Retail Pharmacies

Rise in the number of poliomyelitis therapeutics delivered through retail pharmacies and the rise in the number of retail pharmacies in highly developed countries create opportunities for the market growth. In addition to this, patients choose retail pharmacies for purchasing drugs, as these are easily accessible.

Restraints/Challenges

• Ineffetiveness of the Poliomyelitis Vaccine

As per the reports of several research studies, immunization with inactivated polio vaccines are less effective. For instance, inactivated polio vaccines (IPV) weaken immunity in the intestine. Furthermore, after immunization with IPV, every person gets infected with wild poliovirus, which multiply in the intestines.

• Side Effects of Vaccines

Many side effects associated with poliomyelitis vaccines surely hamper the market growth. Side effects such as fever, chills, pain and soreness, and many such effects restrain the growth of the market.

This global poliomyelitis vaccine market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global poliomyelitis vaccine market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Impact of COVID-19 on Global Poliomyelitis Vaccine Market

With the onset of the COVID-19 pandemic, its vaccine development increased greatly. It hampered the global poliomyelitis vaccine market. The market faced a bit of setback during the pandemic. But in the post pandemic era, as the cases were decreasing and the focus was shifting towards the other diseases and vaccine development, the poliomyelitis faced a highrise and its expected to witness a huge growth in the coming years.

Global Poliomyelitis Vaccine Market Scope

The global poliomyelitis vaccine market is segmented on the basis of vaccines type, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Vaccines Type

• Polio Vaccine (IPV)
• Oral Polio Vaccine (OPV)

End User

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Poliomyelitis Vaccine Market Regional Analysis/Insights

The global poliomyelitis vaccine market is analysed and market size insights and trends are provided by vaccines type, distribution channel and end-user as referenced above.

The major countries covered in the global poliomyelitis vaccine market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America has been witnessing a positive growth for global poliomyelitis vaccine market throughout the forecasted period due to the increased patient awareness level as well as high prevalence of poliomyelitis and strong immunization programme by government.

Asia-Pacific dominates the market due to increased awareness about the diseases and increased government initiatives.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Poliomyelitis Vaccine Market Share Analysis

The global poliomyelitis vaccine market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global poliomyelitis vaccine market.

Key players operating in the global poliomyelitis vaccine market include:

• Pfizer Inc. (U.S.)
• GSK plc (U.K.)
• Novartis AG (Switzerland)
• Mylan N.V. (U.S.)
• Sanofi (France)
• Boehringer Ingelheim International GmbH. (Germany)
• Merck & Co., Inc. (U.S.)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Bristol-Myers Squibb Company (U.S.)
• Astellas Pharma Inc. (Japan)
• Serum Institute of India Pvt. Ltd (India)
• BIO-MED (India)
• HAFFKINE BIO-PHARMACEUTICAL CORPORATION LTD. (India)

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.

The key

SKU-54054